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ABSTRACT³ 
Background²Targeted localized biopsies and treatments for diffuse gliomas rely on accurate 
identification of tissue subregions, for which current MRI techniques lack specificity.  
Purpose²To explore the complementary and competitive roles of a variety of conventional and 
quantitative MRI methods for distinguishing subregions of brain gliomas.   
Study Type²Prospective  
Population²51 tissue specimens were collected using image-guided localized biopsy surgery from 10 
patients with newly diagnosed gliomas. 
Field Strength/Sequence²Conventional and quantitative MR images consisting of pre and post-
contrast T1w, T2w, T2-FLAIR, T2-relaxometry, DWI, DTI, IVIM, and DSC-MRI were acquired pre-
operatively at 3T . 
Assessment²Biopsy specimens were histopathologically attributed to glioma tissue subregion 
categories of active tumor (AT), infiltrative edema (IE), and normal tissue (NT) subregions. For each 
tissue sample, a feature vector comprising of 15 MRI-based parameters was derived from pre-operative 
images and assessed by a machine learning algorithm to determine the best multi-parametric feature 
combination for characterizing the tissue subregions.  
Statistical Tests² For discrimination of AT, IE, and NT subregions, one-way ANOVA test and for 
pairwise tissue subregion differentiation, Tukey-HSD and Games-Howell tests were applied (P<0.05). 
Cross-validated feature selection and classification methods were implemented for identification of 
accurate multi-parametric MRI parameter combination. 
Results² After exclusion of 17 tissue specimens, 34 samples (AT=6, IE=20, and NT=8) were considered 
for analysis. Highest accuracies and statistically significant differences for discrimination of IE from NT 
and AT from NT were observed for diffusion-based parameters (AUCs>90%), and perfusion-derived 
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parameter as the most accurate feature in distinguishing IE from AT. A combination of ³CBV, MD, 
T2_ISO, FLAIR´ SDUDPHWHUV VKRZHG KLJK GLDJQRVWLF SHUIRUPDQFH IRU LGHQWLILFDWLRQ RI WKH WKUHH
subregions (AUC~90%).   
Data Conclusion²Integration of a few quantitative along with conventional MRI parameters may provide 
a potential multi-parametric imaging biomarker for predicting the histopathologically-approved glioma 
tissue subregions. 
KEYWORDS³ Glioma, Imaging Biomarker, Intra-tumor Heterogeneity, Multi-parametric MRI, Machine 
Learning   
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INTRODUCTION 
Diffuse gliomas manifest extensive diffuse infiltration of tumor cells in adjacent brain parenchyma (1). 
Even when low grade, diffuse gliomas are generally fatal after several years (1,2). It is widely known that 
characteristic spatial intra-tumor variability within microenvironment of gliomas account for grim prognosis 
of these patients (3,4). Within heterogeneous tumors like gliomas, multiple subregions with different 
phenotypic characteristics coexist, which often represent heterogeneous genetic and microenvironmental 
profiles, likely to respond variably to treatment (5,6). Lack of sensitive and specific quantitative imaging 
biomarkers for realizing spatial variations of gliomas and localizing the most aggressive portion of the 
tumor leads to inaccurate biopsy sampling, which hinders target-specific diagnosis and therapies (5).     
Targeted biopsy procedures and surgical/treatment planning for gliomas most often rely on conventional 
contrast-enhanced T1-weighted (CE-T1w) and T2-weighted (T2w) and T2-FLAIR images (7-9). 
Nonetheless, as diffuse gliomas tend to invade the brain tissue in small cell groups, tumor expansion and 
progression may precede changes in contrast enhancement (1,8). Furthermore, CE-T1w cannot 
sufficiently localize the most aggressive or active tumor sub-compartment to ensure reliable biopsy 
outcome (10,11). On the other hand, T2w hyperintense regions are incapable of characterizing the 
infiltrative glioma sub-region (infiltrative edema, also referred to as non-enhancing tumor (NET)), and 
diffuse infiltrating cells can be found beyond the extent of T2w hyperintensity borders (12,13). Hence, 
based on conventional MRI, stratification of the most aggressive/active part of the tumor and infiltrative 
glioma and detection of the extent of invasion from normal tissue remains challenging.  
Various advanced MRI contrasts have been explored for their potential in localizing and grading glioma 
brain tumors. Diffusion weighted imaging (DWI) and diffusion tensor imaging (DTI) reflect the water proton 
mobility related to changes in cellular density, permeability of the cell membrane, and tissue 
microstructure(14,15). Perfusion-weighted imaging (PWI) visualizes microvascular changes and cellular 
proliferation; particularly, regional cerebral blood volume (rCBV) derived from dynamic susceptibility 
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contrast enhanced (DSC)-MRI, correlates with the degree of neo-vascularization and histopathological 
grade surpassing the performance of CE-T1w MRI (16-18).  
There have been sporadic attempts to study the role of quantitative MRI methods, including DSC-MRI, 
DWI/DTI, IVIM, and T2-relaxometry for characterizing infiltrating glioma regions through biopsy validation 
(18-20). Hence, we sought to  address:  (1) the roles of individual MRI-derived parameters in 
differentiation of the three subregions, i.e. AT, IE, and NT, from each other; (2) the relationship among 
MRI-derived parameters with histopathological cellular density; and (3) the best multi-parametric 
combination of MRI-derived features for discrimination of AT, IE, and NT through a quantitative 
methodology. 
MATERIALS AND METHODS 
Patients 
Between July 2015 and February 2016, 10 adult patients (6 men and 4 women; mean age 40.4 years; 
age range, 20-76 years) with newly diagnosed gliomas were prospectively recruited in this study. The 
patients underwent pre-surgical MRI and CT examinations, followed by image-guided neurosurgery 
within 1-3 days from image acquisition. Institutional review board (IRB) approval was obtained and the 
patients provided their informed written consent to be included in this study, designed in compliance with 
Health Insurance Portability and Accountability Act (HIPAA) law. Inclusion criteria for this study consisted 
of patients: (1) with suspected glioma brain tumors based on their initial MR scan; (2) with no prior 
treatment, including surgery or radiotherapy; (3) having no contra-indications for surgery; (4) in whom the 
tumor was not in eloquent area; and (5) for whom there were no technical challenges for performing 
surgery. 
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Patients or biopsy specimens were excluded if (1) they did not undergo surgery; (2) imaging was 
performed inadequately or some image sequences were missing; and (3) if histopathological assessment 
of gross tumor or specimens were impossible or not provided. 
Image Acquisition 
All patients underwent pre-operative MRI acquisition within two days prior to their surgery. Structural and 
physiological MRI acquisitions were performed on a 3T MRI scanner (Siemens MAGNETOM Tim Trio, 
Erlangen, Germany). Sagittal T2w turbo spin echo (TE/TR=80/6000, Slice Thickness = 5 mm, Flip Angle 
= 140°, FOV = 230×230 mm2, Image Matrix = 320×320, Pixel size = 0.72×0.72 mm2). Axial T2w turbo 
spin echo (TE/TR=106/5400, Slice Thickness = 5 mm, Flip Angle = 120°, FOV = 200×200 mm2, Image 
Matrix = 232×256, Pixel size = 0.78×0.78 mm2). Axial fluid attenuated inversion recovery (FLAIR) 
(TE/TR/TI = 115/8400/2240, Slice Thickness = 5 mm, Flip Angle = 125°, FOV = 181×200 mm2, Image 
Matrix = 232×256, Pixel size= 0.78×0.78 mm2). Axial 3D MP-RAGE T2w spin-echo as a part of image-
guided surgery protocol with TE/TR = 200/2500, Slice Thickness = 1 mm, Flip Angle = 120°, FOV = 
208×256 mm2, Image Matrix = 420×512, Pixel size= 0.50×0.50 mm2.  
Axial DWI using echo-planar imaging (EPI) sequence with TE/TR = 100/4000, Slice Thickness = 5 mm, 
Flip Angle = 90°, FOV = 200×200 mm2, Image Matrix = 136×136, Pixel size = 1.47×1.47 mm, b-value = 
50, 1000 s/mm2). Axial multi b-value DWI using EPI method with TE/TR = 100/4000, Slice Thickness = 5 
mm, Flip Angle = 90°, FOV = 200×200 mm2, Image Matrix = 136×136, Pixel size = 1.47×1.47 mm2, b-
values = 0, 50, 200, 400, 600, 800, 1000 s/mm2. Diffusion tensor imaging (DTI) with 64 directions and 
TE/TR = 90/9000, Slice Thickness = 5 mm, FOV = 256×256 mm2, Flip Angle = 90°, NEX = 1, Image 
Matrix = 128×128×72, Pixel size = 1.72×1.72 mm2, b-value = 50, 1000 s/mm2. 
Axial multi-echo T2w spin-echo (T2-relaxometry) was carried out with TR=4000 ms, TE=12, 24, 36, 48, 
60, 72, 84, 96, 108, 120, 132, 144, 156, 168, 180, 192 ms, Slice Thickness = 5 mm, Flip Angle = 180°, 
FOV = 200×200 mm2, Image Matrix = 232×256, Pixel size = 0.78×0.78 mm2. 
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After injection of 0.2 mmol/kg of Gadovist (Bayer Schering Pharma, Berlin, Germany) at a rate of 5 ml/s 
and followed by a 20 mL saline flush, dynamic susceptibility contrast enhanced (DSC-) MRI was acquired 
using GE-EPI sequence with TE/TR = 30/1600, Slice Thickness = 5 mm, FOV = 220×220 mm2, Flip Angle 
= 70°, NEX = 1, Image Matrix = 128×128×20, Pixel size = 1.72×1.72 mm2, Number of Dynamic Scans = 
64, Temporal Resolution = 1.5 s. To minimize the effects of contrast agent extravasation a pre-load of 
contrast agent was administered with about 25% of the total contrast dose about 4 minutes of incubation 
time before the second injection for DSC-MR imaging.  
Pre- and post-contrast axial 3D MP-RAGE T1w spin-echo were also acquired as a part of the protocol 
required for navigation system TE/TR = 5/17, Slice Thickness = 1 mm, Flip Angle = 25°, FOV = 208×256 
mm2, Image Matrix = 208×256, Pixel size = 1×1 mm2. 
MR imaging pulse sequences and their parameter adjustments are summarized in Table 1. 
Computed tomography (CT) images were acquired for all patients prior to surgery to ensure accurate 
registration of the images with the position of the patient during image-guided neurosurgery. 3D images 
were acquired on a 64-slice CT scanner (GE Healthcare Technologies, WI, USA) with no gantry tilt, slice 
thickness of 0.625 mm, from maxilla to the top of the head.  
Quantification of MR Images 
Diffusion Tensor Imaging (DTI) 
Quantification of DTI was executed in ExploreDTI software (v4.8.6)(21) with proper parameter 
adjustments, and after EPI and patient motion correction. Maps of mean diffusivity (MD), fractional 
anisotropy (FA), and L1, L2, and L3 eigenvalues were exported from the software. Pure isotropic diffusion 
and pure anisotropic diffusion maps denoted by P and Q, respectively, were calculated based on this 
formula (22): 
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Dynamic Susceptibility Contrast-Enhanced (DSC-) MRI 
DSC-MRI analysis was carried out based on an algorithm developed in-house, which inputs signal 
intensity-time curves of T2*-based dynamic images in each pixelFRQYHUWVWKHPWRǻR2* curves, selects 
the arterial input function (AIF) based on a modified automated algorithm, performs decorrelation using 
block-circulant SVD, and generates regional CBV (rCBV) map.  
T2/Proton Density Mapping 
In T2-relaxometry, images are acquired at multiple echo times to obtain an estimate of T2 and proton 
density by fitting the following equation to the signal: 
2
0
TE
TS S e
  
where S0 is the proton density and T2 is the spin-spin relaxation. Quantitative T2 and proton density (PD) 
maps were generated by pixelwise fitting of the mentioned equation to the corresponding multi-echo 
signal.  
Quantification of Intra-Voxel Incoherent Motion  
Diffusion-weighted images are highly affected by flow of blood and cerebrospinal fluids at very low b-
values (i.e. less than 100-200 s/mm2) (23,24). Here, to separate contributions of diffusion and perfusion, 
the bi-exponential intra-voxel incoherent motion (IVIM) model is which is denoted by: 
*
0( (1 ) )D b DbS S fe f e     
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where S0 is the signal at b-value of zero, f is the fraction of signal affected by flow, D* describes the decay 
of signal caused by flow, D is the measured diffusion coefficient which is a function of diffusion time. To 
nullify the effect of flow on diffusion measurements, diffusion coefficients (D) for each voxel were 
calculated using conservative minimum b-values of 200 s/mm2 (26). As diffusion parameters are highly 
affected by non-Gaussian behavior of diffusion at higher b-values, for calculation of D, this effect was 
conservatively cancelled by using maximum value of 600 s/mm2. 
To account for non-Gaussianity of the signal in higher b-values, the modified IVIM model including 
diffusion kurtosis imaging (IVIM-DKI) was considered (25): 
ܵ ൌ ܵ଴ ቆ݂݁ି௕஽כ ൅ ሺͳ െ ݂ሻ݁ି௕஽ା௕మ஽మ௄଺ ቇ 
where K is the kurtosis factor that measures deviation from the Gaussian behavior. D for each voxel was 
estimated by fitting the equation to the segment of the signal at b-values of 200, 400, and 600 s/mm2 and 
K was estimated on b-values of 600, 800, and 1000 s/mm2 using nonlinear least-squares method.  
 
Biopsy Site Selection  
The generated maps from different modalities, including rCBV-map from DSC-MRI, ADC-map from DWI,  
FA, MD, P, Q from DTI, D, D*, f, and K -maps from multi b-value diffusion imaging, T2 and PD maps from 
T2-relaxometry technique, and conventional images comprising of FLAIR, T2_ISO (MP-RAGE T2w), and 
MP-RAGE pre-contrast T1w, were co-registered with post-contrast MP-RAGE T1w (CE-T1w) image 
using rigid registration method with normalized mutual information (NMI) as the similarity measure in 
SPM software (http://www.fil.ion.ucl.ac.uk/spm/). The difference between post- and pre-contrast T1w 
images was calculated to form T1_SUB (subtracted T1w) image, which shows the enhanced regions 
(Fig. 1).  
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A senior radiologist (K. F. with 12 years of experience in neuroradiology) identified the biopsy targets, i.e. 
active tumor, infiltration, and normal regions, based on presence of hyperintensity on CE-T1w, 
hypointensity on T2w and FLAIR images, and according to quantitative ADC and rCBV maps.  
Rectangular regions of interest (ROIs) with sizes of at most 8x8 pixels were marked on CE-T1w images 
and imported into the navigation workstation to plan for image-guided biopsy intervention. The regions 
were ideally identified on areas with best accessibility for the neurosurgeon for specimen collection and 
distant from vessels, ventricles, and critical brain regions.  
Image-Guided Tissue Biopsy Procedure 
The specimens were sampled from the patients by a senior neurosurgeon (M. Z. with 10 years of 
experience in neurosurgery) using disposable biopsy needle (Stryker Inc., Switzerland). The coordinates 
of the ROIs were recorded by the navigation system (OpticVisionTM, Parseh Intelligent Surgical Systems 
Co. (PARSISS), Iran), which were used to overlay on the images and MRI-derived quantitative maps. 
Based on the guide provided by navigation, needle biopsy was performed on all target points. For each 
patient, 4 to 6 specimens with at least 1-cm of distance were collected for histopathological assessments.  
These technical considerations were addressed during the biopsy to minimize intra-operative brain shift 
and error: 
1- The target points were pre-surgically marked in the order of normal tissue, edema, tumor, and 
necrosis; 
2- Serum manitol, corticosteroids or any other diuretics pre-/intraoperative were not given to 
patients prior to biopsy procedure; 
3- Hypo/hyperventilation during surgery was avoided; 
4- Minimal dural opening was performed to prevent CSF egress resulting in brain shift; 
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5- The target points in proximity of the ventricles were the last points for biopsy, to avoid unwanted 
entrance into the ventricles resulting in CSF  drainage and therefore changing navigation 
accuracy due to brain shift; 
6- For the target points in proximity of cystic portions within the tumor, similar strategy was adopted. 
After needle biopsy, the dura was opened and based on pre-operative images, complete resection of the 
tumor was performed and the resected gross tumor volume was transferred for histopathological grading.  
 Histopathological Assessment of Tissue Samples 
After being removed from the brain, the specimens were fixed in 10% buffered formalin and routinely 
processed for histopathological assessment. Five micrometer sections were stained using hematoxylin 
and eosin (H&E) method and reviewed by a patholologist (F. A. with 20 years of experience in 
neuropathology).  For each specimen, the pathologist determined the presence of tumor cells and scored 
the samples as ³QRUPDOWLVVXH´ZKHre no tumor FHOOVZHUHLGHQWLILHG³SRVLWLYHWXPRUFHOOs´ZKHQLQILOWUDWLQJ
tumor cells were present, DQG³WXPRUFRUH´ZKHQ tumor constituted the majority of tissue. Tumor was 
identified, classified and graded based on morphological features, such as density and distribution of 
cells, nuclear atypia, mitotic activity, vascular proliferation and necrosis. Throughout this manuscript, we 
UHJDUG WKHSDWKRORJLFDO WHUP ³WXPRUFRUH´DV ³DFWLYH WXPRU $7´ ³SRVLWLYH WXPRUFHOOV´DV ³LQILOWUDWLQJ
HGHPD,(´DQG³QRUPDOWLVVXH´DV³QRUPDOWLVVXH17´ 
For each specimen, the area with the highest cellularity was selected and one image was captured at 
x40 magnification. Quantitative assessment of histology images was performed automatically by a cell 
segmentation method which applies decorrelation and stretching of the colorspace in the preprocessing 
step for improving the performance of cell segmentation (Fig. 2) (27). Cellular count (CC) within the 
specified area was calculated from the segmented images and used as a representative parameter of 
cellular density. The relationship between the calculated CC on all regions and interpretation of the 
pathologist, as the gold standard, was examined.   
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Statistical Analysis 
The statistical analysis comprised of the following steps: (1) evaluating the association of MRI-derived 
parameters with each other and with statistically significant quantitative histopathological feature(s); (2) 
assessment of each of the mean values of the extracted features among the three tissue subtypes, i.e. 
infiltrative edema (IE), normal tissue (NT), and active tumor (AT); (3) investigating the diagnostic 
performances of individual MRI-derived features for identifying the histopathologically-identified regions 
and their combinations based on a machine learning technique, comprising automatic feature selection 
and classification.  
The computed MRI-based features (n=15) include morphological parameters, i.e. T1_SUB, T2_ISO, 
FLAIR, diffusion-related parameters, i.e. ADC, MD, FA, P, Q, D, D*, K, perfusion-related parameters, i.e. 
CBV, and f, and T2-relaxometry parameters, i.e. T2 and PD. Histopathological CC metric was also 
evaluated for its potential in discriminating the sub-regions. All statistical analysis and machine learning 
procedures were performed in R Statistical Software (R3.0.2, Vienna, Austria). 
Comparison of Mean Values²One-way ANOVA method was applied to evaluate the discrimination of 
normal tissue (NT), infiltrative edema (IE), and active tumor (AT) tissue subtypes based on the MRI-
derived parameters and cellular count. P-value<0.05 was considered significant for differentiation of the 
three tissue regions simultaneously. For each parameter, pairwise differentiation of the regions, namely 
NT from IE, NT from AT, and IE from AT, was assessed by post-hoc tests, namely 7XNH\¶V KRQHVW
significant difference (Tukey-HSD) or Games-Howell methods, to avoid Type I errors by adjusting the 
calculated p-values for multiple comparisons.  The HSD test is based on assumptions of normality and 
equality of variance, which the former was evaluated using normality tests and the latter by Bartlett 
method. If equality of variance assumption passed, Tukey-HSD was performed; otherwise, Games-
Howell nonparametric test was applied.   
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Association of Parameters²Relationships between MRI-derived parameters with each other and also 
between them and cellular count were obtained using 6SHDUPDQ¶VUDQNFRUUHODWLRQ. To correct for multiple 
comparisons, +ROP¶VPHWKRGIRUPXOWLSOHWHVWLQJZDVDSSOLHG (28) and after correction, a level of 0.05 
was considered statistically significant.  
Assessment of Diagnostic Performances of Individual MRI-derived Parameters² )LVFKHU¶V OLQHDU
discriminant analysis (LDA) method was used to assess performances of MRI-derived and CC 
parameters in discrimination of NT from IE, NT from AT, and IE from AT. LDA was implemented with 
leave-one-out cross validation (LOOCV), where in each iteration (number of iterations equals the number 
of samples), the dataset is partitioned into the training set composed of whole data excluding one sample, 
which is separated as the test object. Assessment metrics, namely sensitivity, specificity, accuracy, and 
area under the receiver operating characteristic (ROC) curve (AUC) were calculated on test samples and 
averaged over loops of cross-validation. 
Combination of MRI-derived Parameters through Classification² To identify the 
complementary/competitive values of MRI-derived features, feature selection was carried out using 
Akaike Information Criterion (AIC) (29) and Schwarz Bayesian Information Criterion (BIC) (30) in forward 
selection, backward elimination and stepwise selection strategies (constructing 6 feature selection 
methods) on a feature space consisting of the 15 MRI-derived parameters.  
The feature selection algorithm was adjusted to avoid choosing similar parameters in a set, e.g. the 
algorithm should select only one feature among diffusion-related features: ADC, D, MD, P; anisotropy-
related features: FA, Q; perfusion-related features: f, CBV; T2-related features: T2, T2_ISO.  
Feature selection was performed in loops of LOOCV and the most frequently selected feature subsets 
by each of the feature selection methods were the representative feature subset (31). This was followed 
E\ D FODVVLILFDWLRQ VWHS EDVHG RQ )LVFKHU¶V OLQHDU GLVFULPLQDQW DQDO\VLV /'$ TXDGUDWLFGLVFULPLQDQW
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analysis (QDA), and support vector machine (SVM) methods (32) for discrimination of tissue subtypes. 
To avoid bias, classification was also performed using LOOCV.  
RESULTS 
Among the 10 recruited patients, 6 were diagnosed with low grade glioma (WHO Grade II: low-grade 
astrocytoma (n=3), diffuse oligoastrocytoma (n=2), oligodendroglioma (n=1)), 1 with anaplastic 
oligoastrocytoma (WHO Grade III), and 3 with glioblastoma multiforme (WHO Grade IV).  A total of 51 
tissue specimens were collected from ten patients. Three patients (2 GBM and 1 Grade II 
Oligodendroglioma) were excluded due to absence or distorted multi b-value, multi-echo, DTI or DSC-
MRI. Finally, seven patients with 34 samples were included in the study. Based on qualitative 
histopathological assessment, 6 samples were diagnosed as WKH³WXPRUDOFRUH´, 20 samples as ³SRVLWLYH
WXPRUFHOOV´DQG8 samples as ³QRUPDOWLVVXH´ 
Relationship of MRI Parameters 
The summary results for correlations among the MRI parameters with each other and with CC are 
provided in Table 2. The statistically significant correlations are stated in boldface type and are shaded 
in gray. 
Diffusion-based parameters²ADC parameter significantly correlated with MD, P, D, T2_ISO and T2 and 
negatively with FA and K. This parameter showed strongest correlations with D (R=0.96), MD (R=0.91), 
P (R=0.88), and T2 (R=0.80), showed no significant correlation with CC. 
D is directly correlated with ADC, FA, MD, P, T2_ISO, T2, and inversely correlated with K. The strongest 
correlation of D was with ADC (R=0.96), MD (R=0.90), and P (R=0.88). It showed significant correlation 
with CC (R=0.40).   
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D* was correlated poorly and inversely with T2. K correlated inversely with ADC, MD, P, and T2 (in all, 
R0.62).  Besides the correlations mentioned earlier that included MD, this parameter was strongly 
correlated with P (R=0.98) and T2 (R=0.84), and showed moderate correlations with T2_ISO. P was 
highly related to T2 (R=0.81), and moderately correlated with T2_ISO. Both MD and P were correlated 
with CC (R=0.36). 
FA was strongly correlated with Q (R=0.86) and indicated modest inverse association with ADC, D, MD, 
P, and T2. Furthermore, FA showed an inverse correlation with CC (R=-0.37). Q was directly correlated 
with FA, and showed no relationships with CC. 
Perfusion-based parameters²CBV only showed statistically significant correlation with f parameter 
derived from IVIM which was not strong (R=0.35). Additionally, it indicated a significant correlation with 
CC (R=0.46). Parameter f correlated with none of the parameters except CBV.  
cMRI parameters²FLAIR only correlated with T2_ISO with correlation coefficient of 0.67. T2_ISO was 
significantly associated with ADC, D, MD, FA, FLAIR, and P (for all, R<0.70). T1_SUB showed no 
significant correlations with any of the parameters. 
T2-mapping parameters²As mentioned in previous sections, T2 demonstrated correlations with ADC, D, 
K, MD, P, and T2_ISO. PD-map correlated with none of the parameters.  
Association of Tissue Subtypes with Quantitative MRI-derived Parameters 
Comparison of the mean values of individual parameters based on ANOVA test for differentiation of the 
three tissue subtypes from each other is stated in Table 3. The results suggest that among MRI-derived 
parameters, T2_ISO, FLAIR, ADC, CBV, MD, FA, P, D, and T2 show statistically significant differences 
among the three subregions, i.e. NT, IE, and AT. Histopathologically-derived parameter, CC, showed 
statistically significant differences among the three tissue subregions (P = 8.9E-06). 
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The details of classification performances of individual parameters in differentiation of each of the two 
subregions from each other and based on cross-validated LDA method are given in Table 3. For 
differentiation of NT from IE (requiring high sensitivity), highest performances were for T2_ISO, FLAIR, 
ADC, MD, P, D, and T2. T2-based features, i.e. T2_ISO, FLAIR, and T2 resulted in AUCs>84% for this 
discrimination. The four diffusion-related parameters, i.e. ADC, MD, P, and D resulted in AUCs of over 
90% (and sensitivities >90%) for discrimination of NT from IE. In this context, T1_SUB, CBV, and f were 
highly sensitive (100%) but lack specificity. 
All MRI-derived parameters except for D*, f, and PD were accurate for separation of NT from AT, implying 
high sensitivity of these metrics.  
The only statistically significant MRI-derived feature for identification of IE from AT was DSC-MRI-derived 
parameter, i.e. CBV, with high specificity of 95%.  
CC showed high AUCs for differentiation of the three two-by-two subregions (>84%), although its 
specificity for separation of NT from IE was rather low. 
Combination of Quantitative MRI-derived Parameters 
For classification of the three tissue subtypes from each other, i.e. NT, IE, and AT, four feature 
combinations were selected by the feature selection methods: (1) CBV, MD, FLAIR, T2_ISO (selected 
by Backward AIC); (2) CBV, MD (selected by Backward BIC); (3) CBV, D, T2_ISO (Forward/Stepwise 
AIC); and (4) CBV, D (selected by Backward BIC) (Table 4). Three classification methods, namely, LDA, 
QDA, and SVM, were applied on the selected combinations. As Table 4 summarizes, using the 
classifiers, the most accurate feature VHWZDV³CBV, MD, FLAIR, T2_ISO´with AUC of ~90% for all three 
classifiers. Additionally, the feature FRPELQDWLRQ³&%9'7B,62´resulted in AUC of ~92% using LDA 
classification scheme. 
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Table 5 should assess the performances of classification schemes (each classifier on the selected 
feature subsets) for two-by-two discrimination of the three subregions from each other. Combination of 
³CBV, MD, FLAIR, T2_ISO´XVLQJHLWKHU4'$RU690FODVVLILHUVproduces accurate results for all the 
three discrimination purposes, i.e. NT from IE, NT from AT, and IE from AT. Using QDA, this combination 
indicates AUC of 92.3% for characterization of NT from IE, 100% for NT from AT, and 89.2% for IE from 
AT. SVM classification based on this combination results in AUC of 98.8% for identification of NT from 
IE, 100% for NT from AT, and 100% for IE from AT. 
$GGLWLRQDOO\³&%9'7B,62´using QDA classifier can generate AUC of 85.6% for differentiation of NT 
from IE, 100% for NT from AT, and 91.6% for IE from AT. 
DISCUSSION 
Conventional MR imaging lacks accuracy in assessing physiological variations and regional 
heterogeneity within tumors. During the past years, several quantitative methods, such as DWI/DTI and 
DSC-MRI, have been investigated for their potential as adjuncts to cMRI. Yet, the comparative and 
complementary roles of these methods and emerging techniques, such as T2-relaxometry and IVIM, are 
not explored especially through histopathologically-approved specimens and objective classification 
techniques.  
In this preliminary study, we attempted to tackle this problem by evaluation of the aforementioned 
techniques on localized biopsy specimens, which were histopathologically assessed and attributed to 
active tumor (AT), infiltrative edema (IE), and normal tissue (NT) subregions. Among individual MRI-
derived parameters, diffusion-related ADC, MD, P, D parameters, as markers of cellular proliferation, 
indicated high classification performance for identification of NT from IE, and NT from AT, but were not 
suitable for IE from AT separation. This finding along with significant correlation of D, MD, and P with 
histopathological CC parameter, suggests that changes in cellular distribution captured by diffusion-
based parameters can be early markers of glioma infiltration (NT from IE discrimination). But, these 
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changes in low-grade glioma are not significantly different among IE and AT subregions; therefore, these 
parameters may not be diagnostically valuable for localizing the most active part of the tumor and other 
features must be explored. Among FA and Q as indicators of diffusion anisotropy, FA was statistically 
significant for discrimination of the three subregions and showed significant inverse correlation with CC, 
and accurately discriminated NT from AT.. However, FA did not result in statistically significant differences 
for isolation of NT from IE or IE from AT in our sample population. 
In animal studies, DTI has been shown to identify microinfiltration of tumor cells in the surrounding brain 
tissue (33,34). Early investigations on human brain glioma indicate that DWI/DTI can provide helpful 
information for assessment of peritumoral edema and to define margins of tumor invasion (3,35,36). 
Specifically, apparent diffusion coefficient (ADC) (20,37) or mean diffusivity (MD) and fractional 
anisotropy (FA) (19,38,39) have shown correlations with NET based on histopathologically-approved 
biopsy specimens. 
Unlike other MRI-derived parameters, CBV was the only statistically significant feature for discrimination 
of IE from AT . Hence, early vascularization is a discriminative factor for identifying the most active 
component of gliomas. This parameter was not statistically significant for identification of NT from IE, 
indicating that in early stages of infiltration and before transforming into the most active subpopulations, 
neo-angiogenesis may not have a role in gliomas. CBV was evidently statistically significant for 
characterization of NT from AT. Nonetheless, the classification performance  was lower than that of 
diffusion-based parameters . Suboptimal performance of CBV in contrast to diffusion-based parameters 
in this context can be attributed to our sample population of low-grade gliomas, in which neo-
vascularization has not become largely prominent in the infiltrative or active tumor regions.   
The best combination of these parameters was sought using cross-validated feature selection and 
classification methods. Three classifiers with increasing complexity, namely LDA, QDA, and SVM, were 
implemented to get insights about capability of the selected feature combinations in tissue identification 
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irrespective of classifier formulation. In all four selected feature sets, CBV and a diffusion-based 
parameter like D or MD were present, signifying the importance of perfusion and diffusion parameters in 
subregion characterization. Incorporation of T2_ISO and FLAIR to perfusion and diffusion parameters in 
the form of ³CBV, MD, T2_ISO, and FLAIR´ combination resulted in high classification performance for 
characterization of the three tissue subregions from each other, using the classifiers (AUC~90%). This 
feature set revealed high classification performance in pairwise subregion classification, as well . T2_ISO 
and FLAIR are important factors for illustrating the pathogenic changes within glioma borders. Similar 
integration of parameters has been intuitively employed in brain tumor segmentation elsewhere (40-42).  
A combination of fewer parameters including ³&%9'7B,62´ based on QDA classifier generated a 
relatively high classification performance for pairwise differentiation of tissue subregions . In occasions 
with high risk of patient discomfort and motion, IVIM acquisition combined with DSC-MRI perfusion and 
anatomical high-resolution T2w, required for image-guided neurosurgery, could be performed without 
addition of DTI acquisition, which is highly susceptible to motion. 
Nonetheless, our study and the results achieved are limited by the included patient population and small 
sample size. Furthermore, despite using cross-validation for reducing bias in classification in our work, 
an independent validation dataset is required for generalizing the findings. Finally, in this work, our 
research imaging protocol had to be adapted to the clinical set-up constraints of our academic educational 
institution and therefore, some of the imaging parameters may not be optimal; for example, in quantitative 
imaging sequences, the voxel sizes are non-isotropic. Future works may benefit from optimization of 
parameter specifications for quantitative imaging sequences. 
In conclusion, through investigation of a variety of conventional and quantitative MRI techniques applied 
on histopathologically-approved tissue specimens, we have demonstrated that incorporation of a few 
imaging techniques (comprising of conventional MRI (T2w and FLAIR) and DSC-MRI with DTI or IVIM) 
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can form a multi-parametric surrogate marker, predictive of tissue subregions prior to image-guided 
biopsy procedures. 
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Table 1³MR Imaging Specifications 
Sequence TE/TR  Slice Thickness 
(mm) 
Flip Angle FOV (mm2) Image Matrix Other Specifications 
Pre- and Post-contrast 
3D T1w 
5/17 1 25° 208×256 208×256 N/A 
3D T2w 200/2500 1 120° 208×256 420×512 N/A 
T2-FLAIR 115/8400 5 125° 181×200 232×256 TI=2240 
T2-Relaxometry (12, 24, 36, 48, 60, 72, 
84, 96, 108, 120, 132, 
144, 156, 168, 180, 
192)/4000 
5 180° 200×200 232×256 N/A 
DWI 100/4000 5 90° 200×200 136×136 b-values=50, 1000 
s/mm2 
Multi b-value DWI 100/4000 5 90° 200×200 136×136 b-values=0, 50, 200, 
400, 600, 800, 1000 
s/mm2 
DTI 90/9000 5 90° 256×256 128×128 b-values=50, 1000 
s/mm2 
DSC-MRI 30/1600 5 70° 220×220 128×128 No. Dynamic Scans = 
64, Temporal 
Resolution = 1.5 s 
DWI²Diffusion Weighted Imaging; DTI²Diffusion Tensor Imaging; DSC-MRI²Dynamic Susceptibility Contrast Enhanced MRI;   
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Table 2³Correlations (in terms of R) among the MRI-derived parameters with each other and between MRI-derived parameters and cell count (from 
histopathology) . 
 ADC CBV D D* FA FLAIR f K MD P PD Q T1_SUB T2_ISO T2 Count 
ADC  -0.078 0.96 -0.40 -0.60 0.45 -0.11 -0.71 0.91 0.88 0.28 -0.28 0.13 0.66 0.80 0.30 
CBV   0.01 0.14 -0.25 0.03 0.35 0.17 -0.09 -0.06 0.18 -0.24 0.28 -0.22 -0.19 0.46 
D    -0.31 -0.64 0.46 -0.09 -0.68 0.90 0.88 0.26 -0.31 0.15 0.64 0.78 0.40 
D*     0.30 -0.25 0.15 0.43 -0.38 -0.40 -0.25 0.30 -0.09 -0.30 -0.49 -0.02 
FA      -0.33 0.10 0.58 -0.56 -0.58 -0.41 0.86 -0.20 -0.39 -0.54 -0.37 
FLAIR       0.14 -0.43 0.41 0.44 0.21 -0.14 0.37 0.69 0.34 0.05 
f        0.36 0.01 -0.01 0.07 0.08 0.27 0.10 -0.07 0.32 
K         -0.60 -0.59 -0.18 0.41 -0.19 -0.51 -0.61 -0.09 
MD          0.98 0.46 -0.28 0.19 0.62 0.84 0.36 
P           0.47 -0.31 0.26 0.59 0.81 0.36 
PD            -0.47 0.27 0.02 0.39 0.00 
Q             -0.23 -0.11 -0.34 -0.17 
T1_SUB              0.03 0.03 0.23 
T2_ISO               0.69 0.15 
T2                0.18 
7KHFHOOVZLWKEROG-face type and with gray-VKDGHGFRORUDUHWKRVHZLWKVLJQLILFDQWFRUUHODWLRQDVLQGLFDWHGE\6SHDUPDQ¶VUDQNFRUUHODWLRQ 
ADC²Apparent Diffusion Coefficient (DWI); CBV²Cerebral Blood Volume (DSC-MRI); D²True diffusion coefficient (IVIM); D*²Pseudo-diffusion coefficient (IVIM); f²perfusion fraction (IVIM); K²Diffusion 
Kurtosis; MD²Mean Diffusivity (DTI); FA²Fractional Anisotropy (FA); P²Pure isotropic diffusion coefficient (DTI); Q²Pure anisotropic diffusion coefficient (DTI); PD²Proton Density (T2-relaxometry); T2² T2 
relaxation time (T2-relaxometry); T1_SUB²Subtracted high-resolution T1w from the corresponding high-resolution contrast-enhanced T1w image; T2_ISO²High-resolution T2w image; FLAIR²Fluid-attenuated 
inversion recovery image;   
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Table 3³ Comparison of the Mean Values Based on ANOVA Test (Second Column), for Differentiation of Normal Tissue (NT) vs. Infiltrative Edema 
(IE) vs. Active Tumor (AT) Simultaneously, and Evaluating the Diagnostic Performances of Individual Parameters in Differentiating Pairwise Regions, 
LH´17µIURP´,(µ´17µIURP´$7µDQG´,(µIURP´$7µ8VLQJ&URVV-validated LDA Method .  
Feature 
ANOVA 
Test (P-
values) 
NT from IE NT from AT IE from AT 
P-values Sens. Spec. Acc. AUC (95% CI) P-values Sens. Spec. Acc. AUC (95% CI) P-values Sens. Spec. Acc. AUC (95% CI) 
T1_SUB 0.203 0.563 100 0 71.4 68.8 (45.0 ± 92.5) 0.176 50 100 78.6 81.2 (54.1 ± 100) 0.462 1.9 95.1 73.7 67.5 (36.4 ± 98.1) 
T2_ISO 0.001 0.018 87.0 75.9 83.9 89.4 (77.0 ± 100) 0.000 77.9 87.5 83.5 95.8 (86.0 ± 100) 0.913 0.0 100 76.9 59.1 (35.5 ± 82.8) 
FLAIR 0.001 0.016 89.8 64.7 82.7 90.6 (79.0 ± 100) 0.000 67.9 87.5 79.1 93.7 (81.2 ± 100) 0.958 0.0 100 76.9 49.2 (21.8 ± 76.5) 
ADC 0.005 0.002 89.6 87.5 89.0 90.0 (76.9 ± 100) 0.001 100 87.5 92.9 100 (100 ± 100) 0.473 0.64 100 77.1 65.0 (41.9 ± 88.1) 
CBV 0.004 0.963 100 0 71.4 50.7 (24.1 ± 77.3) 0.003 66.7 87.5 78.6 75.0 (41.1 ± 100) 0.018 51.3 95.4 85.2 80.0 (50.7 ± 100) 
MD 0.000 0.001 93.9 63.8 85.3 93.8 (85.0 ± 100) 0.001 100 100 100 100 (100 ± 100) 0.601 1.3 100 77.2 68.3 (46.3 ± 90.3) 
FA 0.010 0.082 94.6 12.9 71.3 70.6 (50.2 ± 91.0) 0.007 100 85.5 91.8 100 (100 ± 100) 0.209 0.0 100 76.9 86.7 (71.0 ± 100) 
Q 0.116 0.215 100 0 71.4 51.9 (27.5 ± 76.4) 0.104 77.6 80.4 79.7 83.3 (58.6 ± 100) 0.990 5.8 98.6 77.2 82.5 (65.4 ± 99.3) 
P 0.000 0.001 89.7 69.2 84.0 91.9 (81.0 ± 100) 0.002 100 99.1 99.5 100 (100 ± 100) 0.737 0.0 100 76.9 60.0 (35.3 ± 84.7) 
D 0.000 0.002 90.0 71.4 84.9 90.6 (78.6 ± 100) 0.000 100 94.0 96.7 100 (100 ± 100) 0.251 9.9 99.0 78.5 68.3 (46.0 ± 90.6) 
D* 0.748 0.918 98.9 0.9 70.9 60.6 (31.8 ± 89.5) 0.734 41.2 74.1 61.5 60.4 (24.4 ± 95.9) 0.855 0.0 100 76.9 52.2 (23.5 ± 80.8) 
f 0.505 0.941 100 0 71.4 52.0 (27.1 ± 76.8) 0.504 32.6 86.1 63.7 59.5 (27.8 ± 90.7) 0.574 0.6 97.6 75.2 64.2 (39.9 ± 88.4) 
K 0.1136 0.906 93.5 14.9 71.2 73.7 (52.9 ± 94.6) 0.165 83.3 86.5 85.2 87.5 (65.8 ± 100) 0.145 0 100 76.9 55.8 (32.4 ± 79.3) 
T2 0.018 0.024 93.3 66.8 86.0 84.4 (65.4 ± 100) 0.041 83.3 87.5 85.7 87.5 (67.8 ± 100) 0.890 0.0 100 76.9 50.1 (24.4 ± 75.8) 
PD 0.282 0.461 100 0.51 71.6 66.9 (43.0 ± 90.7) 0.272 42.9 86.5 68.1 72.9 (42.7 ± 100) 0.738 2.1 100 77.4 55.1 (23.4 ± 86.9) 
Count 8.9E-06 0.221 92.5 25.9 73.5 83.8 (68.5 ± 98.9) 1.0E-05 66.7 100 85.7 100 (100 ± 100) 6.1E-05 66.7 99.8 92.1 91.7 (79.2 ± 100) 
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7KHYDOXHVZLWKEROG-face type under the P-values column are those with significant P-values based on ANOVA test for simultaneous differentiation of the three regions from each other, and 
also pairwise differentiation of the regions based on Tukey-HSD or Games-Howell tests (whichever was appropriate for each of the parameters). The bold-face type values under other columns 
indicate high accuracy.
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Table 4³ Evaluating accuracy and diagnostic performances (AUC) of LDA, QDA, and SVM 
classifiers on the selected features . 
Feature Selection 
Method 
Selected Features Accuracy 
(%) 
AUC (95% CI) 
(%) 
Cross-Validated LDA 
Backward AIC CBV, FLAIR, MD, T2_ISO 82.8 89.3 (75.9 ± 100) 
Backward BIC CBV, MD 75.4 74.7 (55.0 ± 94.4) 
Forward/Stepwise AIC CBV, D, T2_ISO 82.1 91.9 (83.1 ± 100) 
Backward BIC CBV, D 74.8 73.2 (54.4 ± 91.6) 
Cross-Validated QDA 
Backward AIC CBV, FLAIR, MD, T2_ISO 85.1 92.4 (84.1 ± 100) 
Backward BIC CBV, MD 79.9 80.0 (61.8 ± 98.0) 
Forward/Stepwise AIC CBV, D, T2_ISO 83.4 85.3 (71.2 ± 99.1) 
Backward BIC CBV, D 81.2 84.8 (69.1 ± 99.4) 
Cross-Validated SVM 
Backward AIC CBV, FLAIR, MD, T2_ISO 91.3 91.9 (79.6 ± 100) 
Backward BIC CBV, MD 80.2 79.8 (61.4 ± 98.1) 
Forward/Stepwise AIC CBV, D, T2_ISO 79.3 83.0 (65.9 ± 99.7) 
Backward BIC CBV, D 79.3 81.4 (63.6 ± 98.8) 
7KH gray-shaded cells with bold-type face numbers or letters indicate highest diagnostic performances. 
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Table 5³ Evaluating classification performances of LDA, QDA, and SVM classifiers on the selected features for differentiation of each of 
two tissue subregions from each other, i.e. NT from IE, NT from AT, and IE from AT . 
Classifiers 
Feature Combinations  NT from IE  NT from AT  IE from AT 
 Sens. Spec. Acc. AUC (95% CI)  Sens. Spec. Acc. AUC (95% CI)  Sens. Spec. Acc. AUC (95% CI) 
L
D
A
 
CBV, FLAIR, MD, 
T2_ISO 
 90.0 86.8 89.1 94.8 (86.4 ± 100)  100 100 100 100 (100 ± 100)  57.9 99.8 90.1 92.0 (80.0 ± 100) 
CBV, MD  91.1 65.9 84.0 92.6 (83.1 ± 100)  100 100 100 100 (100 ± 100)  62.3 99.6 91.1 91.5 (79.0 ± 100) 
CBV, D, T2_ISO  86.1 94.1 88.5 91.7 (80.5 ± 100)  100 100 100 100 (100 ± 100)  50.6 100 88.6 91.4 (78.6 ± 100) 
CBV, D  89.6 64.2 82.5 90.0 (77.7 ± 100)  100 100 100 100 (100 ± 100)  50.6 100 88.6 91.3 (78.3 ± 100) 
Q
D
A
 
CBV, FLAIR, MD, 
T2_ISO 
 85.2 99.5 89.3 92.3 (83.9 ² 99.9)  100 100 100 100 (100 ² 100)  84.1 94.4 92.0 89.2 (72.5 ² 100) 
CBV, MD  86.6 73.4 82.9 80.0 (61.6 ± 98.0)  100 100 100 100 (100 ± 100)  66.7 99.6 92.0 83.1 (83.1 ± 100) 
CBV, D, T2_ISO  81.4 89.8 93.9 85.6 (71.7 ² 99.0)  100 100 100 100 (100 ² 100)  83.3 99.8 96.0 91.6 (91.6 ² 100) 
CBV, D  85.5 83.4 85.1 84.5 (68.6 ± 99.3)  100 100 100 100 (100 ± 100)  61.1 100 91.1 80.6 (59.1 ± 98.9) 
S
V
M
 
CBV, FLAIR, MD, 
T2_ISO 
 94.6 89.8 93.3 98.8 (95.9 ² 100)  100 100 100 100 (100 ² 100)  85.4 100 96.6 100 (100 ² 100) 
CBV, MD  93.7 65.2 85.6 94.6 (86.8 ± 100)  100 100 100 100 (100 ± 100)  69.5 100 92.9 93.5 (80.2 ± 100) 
CBV, D, T2_ISO  88.3 86.9 88.0 92.9 (82.9 ± 100)  100 100 100 100 (100 ± 100)  50.6 100 88.6 91.1 (77.8 ± 100) 
CBV, D  91.1 61.4 82.7 91.4 (79.8 ± 100)  100 100 100 100 (100 ± 100)  50.6 100 88.6 91.6 (78.7 ± 100) 
7KH gray-shaded cells with bold-type face numbers or letters indicate highest diagnostic performances of classifiers for all three discrimination 
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FIGURE CAPTIONS 
Fig 1. MR images and quantitative maps of a 20-years old female with histopathologically-confirmed grade 
II Oligodendroglioma (images are coregistered with CE-T1w image) 
Fig 2. Automated segmentation of cells in microscopic images (x40 magnification): (A) a sample image 
from tumor core of the same patient indicated in Fig 1; (B) automated cell segmentation result. 
 
